Cargando…
Modern risk stratification in coronary heart disease
The prevalence and impact of cardiovascular diseases in the world are growing. There are 2 million deaths due to cardiovascular disease each year in the European Union; the main cause of death being the coronary heart disease responsible for 16% of deaths in men and 15% in women. Prevalence of cardi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227156/ https://www.ncbi.nlm.nih.gov/pubmed/22514570 |
_version_ | 1782217684447920128 |
---|---|
author | Ginghina, C. Bejan, I. Ceck, C.D. |
author_facet | Ginghina, C. Bejan, I. Ceck, C.D. |
author_sort | Ginghina, C. |
collection | PubMed |
description | The prevalence and impact of cardiovascular diseases in the world are growing. There are 2 million deaths due to cardiovascular disease each year in the European Union; the main cause of death being the coronary heart disease responsible for 16% of deaths in men and 15% in women. Prevalence of cardiovascular disease in Romania is estimated at 7 million people, of which 2.8 million have ischemic heart disease. In this epidemiological context, risk stratification is required for individualization of therapeutic strategies for each patient. The continuing evolution of the diagnosis and treatment techniques combines personalized medicine with the trend of therapeutic management leveling, based on guidelines and consensus, which are in constant update. The guidelines used in clinical practice have involved risk stratification and identification of patient groups in whom the risk-benefit ratio of using new diagnostic and therapeutic techniques has a positive value. Presence of several risk factors may indicate a more important total risk than the presence / significant increase from normal values of a single risk factor. Modern trends in risk stratification of patients with coronary heart disease are polarized between the use of simple data versus complex scores, traditional data versus new risk factors, generally valid scores versus personalized scores, depending on patient characteristics, type of coronary artery disease, with impact on the suggested therapy. All known information and techniques can be integrated in a complex system of risk assessment. The current trend in risk assessment is to identify coronary artery disease in early forms, before clinical manifestation, and to guide therapy, particularly in patients with intermediate risk, which can be classified in another class of risk based on new obtained information. Abbreviations: ACS = acute coronary syndrome; AMI = acute myocardial infarction; BNP = brain natriuretic peptide; BP = blood pressure; BPs = systolic blood pressure; CHD= coronary heart disease; CRP = C-reactive protein; CX= circumflex artery; EF= ejection fraction; LAD= left anterior descendending coronary artery; LV = feft ventricle; MI= myocardial infarction; NGAL= neutrophil gelatinase associated lipocalin; NT-proBNP = N-terminal pro B-type natriuretic peptide; RCA= right coronary artery; RV= right ventricle |
format | Online Article Text |
id | pubmed-3227156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Carol Davila University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-32271562012-04-18 Modern risk stratification in coronary heart disease Ginghina, C. Bejan, I. Ceck, C.D. J Med Life General Article The prevalence and impact of cardiovascular diseases in the world are growing. There are 2 million deaths due to cardiovascular disease each year in the European Union; the main cause of death being the coronary heart disease responsible for 16% of deaths in men and 15% in women. Prevalence of cardiovascular disease in Romania is estimated at 7 million people, of which 2.8 million have ischemic heart disease. In this epidemiological context, risk stratification is required for individualization of therapeutic strategies for each patient. The continuing evolution of the diagnosis and treatment techniques combines personalized medicine with the trend of therapeutic management leveling, based on guidelines and consensus, which are in constant update. The guidelines used in clinical practice have involved risk stratification and identification of patient groups in whom the risk-benefit ratio of using new diagnostic and therapeutic techniques has a positive value. Presence of several risk factors may indicate a more important total risk than the presence / significant increase from normal values of a single risk factor. Modern trends in risk stratification of patients with coronary heart disease are polarized between the use of simple data versus complex scores, traditional data versus new risk factors, generally valid scores versus personalized scores, depending on patient characteristics, type of coronary artery disease, with impact on the suggested therapy. All known information and techniques can be integrated in a complex system of risk assessment. The current trend in risk assessment is to identify coronary artery disease in early forms, before clinical manifestation, and to guide therapy, particularly in patients with intermediate risk, which can be classified in another class of risk based on new obtained information. Abbreviations: ACS = acute coronary syndrome; AMI = acute myocardial infarction; BNP = brain natriuretic peptide; BP = blood pressure; BPs = systolic blood pressure; CHD= coronary heart disease; CRP = C-reactive protein; CX= circumflex artery; EF= ejection fraction; LAD= left anterior descendending coronary artery; LV = feft ventricle; MI= myocardial infarction; NGAL= neutrophil gelatinase associated lipocalin; NT-proBNP = N-terminal pro B-type natriuretic peptide; RCA= right coronary artery; RV= right ventricle Carol Davila University Press 2011-11-14 2011-11-24 /pmc/articles/PMC3227156/ /pubmed/22514570 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | General Article Ginghina, C. Bejan, I. Ceck, C.D. Modern risk stratification in coronary heart disease |
title | Modern risk stratification in coronary heart disease |
title_full | Modern risk stratification in coronary heart disease |
title_fullStr | Modern risk stratification in coronary heart disease |
title_full_unstemmed | Modern risk stratification in coronary heart disease |
title_short | Modern risk stratification in coronary heart disease |
title_sort | modern risk stratification in coronary heart disease |
topic | General Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227156/ https://www.ncbi.nlm.nih.gov/pubmed/22514570 |
work_keys_str_mv | AT ginghinac modernriskstratificationincoronaryheartdisease AT bejani modernriskstratificationincoronaryheartdisease AT ceckcd modernriskstratificationincoronaryheartdisease |